ATS Literature Review, Consultations & Trial - Odyssey House

Amphetamine‐Type Stimulants: Development of a Treatment Protocol
Figures and Tables
Figure 1: Thorley’s model of drug harm 16
Table 1: Summary of drugs ever used/tried: proportion of the
population aged 14 years or older, Australia, 1993 to 2007
17
Figure 2: Proportion of IDU reporting recent use of crystalline
methamphetamine, by jurisdiction, 2000‐2005
18
Table 2: Summary of recent drug use: proportion of the population
aged 14 years or older, Australia, 1993 to 2007
19
Figure 3: Frequent drug users by gender, 2007: New Zealand 21
Table 3: Drug types used by frequent methamphetamine users in
past six months by age (2006 and 2007 samples combined)
22
Table 4: Frequent drug users by location in New Zealand 23
Table 5: Major risk and protective factors for harmful substance use
across the lifespan
24
Table 6: Key determinants of risk for young people 25
Table 7: Range of responses for diverse target groups 35
Figure 4: Mirikai & Oasis ‐ Primary Drug of Choice 81
Figure 5: Mirikai ‐ Mental Health Primary Diagnosis 81
Table 8: Goldbridge ‐ Main Drug of Concern: 2007‐2008 82
Table 9: Goldbridge ‐ Mental Health Status of Clients: At Assessment
2007‐2008
82
Figure 6: Primary Substance Use of Clients Admitted into the Odyssey
House NSW TC
87
Figure 7: Secondary Drug of Choice Identified by Clients entering the
Odyssey House NSW TC
87
Figure 8: Odyssey House NSW ‐ Comparison 2006/2007 with
2007/2008 Primary Substance Use identified upon admission
to the TC: Percentage of the Total Admissions
88
Figure 9: Clients Admitted to the Odyssey House NSW TC: July 07 to
June 08 with a Dual Diagnosis
88
Figure 10: Grouped by Diagnosis/Drug use – Odyssey House NSW 88
Figure 11: Grouped by Drug Use / Diagnosis: Odyssey House NSW 89
Figure 12: Windana: Total percentages – presenting drug of concern on
admission 2006‐2007
93
Figure 13: Windana: Total percentages – presenting drug of concern on
admission 2007‐2008
93
Figure 14: Cyrenian House ‐ Principal Presenting Drug by Gender 2007‐
2008
97
Figure 15: Cyrenian House ‐ Principal Drug of Concern 2007‐2008 97
Table 10: Karralika ‐ Principal Drug of Concern on Admission 101
Table 11: Karralika ‐ Mental Health Status of Clients: At Admission 101
Table 12: The Peppers ‐ Principal Drug of Concern on Admission 101
Table 13: The Peppers ‐ Mental Health Status of Clients at Assessment 102
Table 14: The Peppers ‐ Mental Health Status of Clients on Admission 102
Figure 16: Age of clients with Methamphetamine use admitted to
Higher Ground
107
Page 6 © Lynne Magor‐Blatch & James A. Pitts: Odyssey House McGrath Foundation 2008‐2009